Podolak-Dawidziak M, Silber-Kasprzak D
Acta Haematol Pol. 1976;7(4):303-9.
Adrenal function was studied in patients with chronic myeloid leukaemia treated in the past or presently with Busulphan. Adrenocortical function was determined by means of 24-hour profile of 11-hydroxysteroids (11-OHCS) in plasma, and urinary 24-hour 17 hydrocorticosteroids (17-OHCS) and 17-ketosteroids (17-KS). The adrenomedullary function was determined measuring VMA level in 24-hour urine. In most patients normal 24-hour 11-OHCS profiles and 24-levels of 17-OHCS, 17-KS and VMA. Only in some cases these levels were raised. This rise was observed more frequently in patients with blastic crisis of myeloid leukaemia which may indicate that the adrenal reserve was maintained in these patients. The investigations failed to show that the disease itself or Busulphan treatment impaired adrenal function. The possibility of a direct effect of Busulphan on melanin metabolism in the organism is discussed.
对过去或目前接受白消安治疗的慢性粒细胞白血病患者的肾上腺功能进行了研究。通过检测血浆中11-羟皮质类固醇(11-OHCS)的24小时变化曲线、尿中24小时17-羟皮质类固醇(17-OHCS)和17-酮类固醇(17-KS)来确定肾上腺皮质功能。通过测量24小时尿中香草扁桃酸(VMA)水平来确定肾上腺髓质功能。大多数患者的24小时11-OHCS变化曲线以及17-OHCS、17-KS和VMA的24小时水平均正常。仅在某些情况下这些水平会升高。在髓系白血病急变期患者中更频繁地观察到这种升高,这可能表明这些患者的肾上腺储备功能得以维持。研究未能表明疾病本身或白消安治疗会损害肾上腺功能。文中还讨论了白消安对机体黑色素代谢产生直接影响的可能性。